A retrospective observational multicenter cohort study assessing the efficacy and safety of nivolumab in patients with unresectable Hepatocellular Carcinoma progressed during Sorafenib treatment
Latest Information Update: 20 Jul 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology
- 22 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020